Whose disease will recur after mastectomy for early stage, node-negative breast cancer? a systematic review

Clinical Breast Cancer

Volumn 15, Issue 6, 2015, Pages 403-412

  Kent, Collin ^a   Horton, Janet ^a,b   Blitzblau, Rachel ^a,b   Koontz, Bridget F ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

Chest wall; Local recurrence; Post mastectomy radiation; Radiotherapy; Triple negative

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; KI 67 ANTIGEN; METHOTREXATE; TAMOXIFEN;

AGE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SIZE; HUMAN; INFORMATION RETRIEVAL; LYMPH VESSEL METASTASIS; MASTECTOMY; MENOPAUSE; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; BREAST NEOPLASMS; CLASSIFICATION; FEMALE; PATHOLOGY; RISK FACTOR; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS;

EID: 84947047292     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2015.06.008     Document Type: Review

References (30)

1. N.P. Rowell Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review Radiother Oncol 91 2009 23 32
2. S. Cleator, W. Heller, and R.C. Coombes Triple-negative breast cancer: therapeutic options Lancet Oncol 8 2007 235 244
3. A.J. Khan, S.A. Milgrom, N. Barnard, and et al. Basal subtype, as approximated by triple-negative phenotype, is associated with locoregional recurrence in a case-control study of women with 0-3 positive lymph nodes after mastectomy Ann Surg Oncol 21 2014 1963 1968
4. M.B. Mukesh, S. Duke, D. Parashar, G. Wishart, C.E. Coles, and C. Wilson The Cambridge post-mastectomy radiotherapy (C-PMRT) index: a practical tool for patient selection Radiother Oncol 110 2014 461 466
5. R. Abi-Raad, R. Boutrus, R. Wang, and et al. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy Int J Radiat Oncol Biol Phys 81 2011 e151 e157
6. M. Overgaard, P.S. Hansen, J. Overgaard, and et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 337 1997 949 955
7. M. Overgaard, M.B. Jensen, J. Overgaard, and et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 353 1999 1641 1648
8. J. Ragaz, S.M. Jackson, N. Le, and et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 337 1997 956 962
9. M. Clarke, R. Collins, S. Darby, and et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
10. S.C. Darby, M. Ewertz, P. McGale, and et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 2013 987 998
11. A. Goldhirsch, W.C. Wood, R.D. Gelber, A.S. Coates, B. Thurlimann, and H.J. Senn Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 2007 133 144
12. A. Recht, S.B. Edge, L.J. Solin, and et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 2001 1539 1569
13. P.T. Truong, I.A. Olivotto, T.J. Whelan, and M. Levine Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy CMAJ 170 2004 1263 1273
14. R.S. Punglia, M. Morrow, E.P. Winer, and J.R. Harris Local therapy and survival in breast cancer N Engl J Med 356 2007 2399 2405
15. Danish Breast Cancer Cooperative Group, H.M. Nielsen, M. Overgaard, C. Grau, A.R. Jensen, and J. Overgaard Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies J Clin Oncol 24 2006 2268 2275
16. EBCTCG (Early Breast Cancer Trialists' Collaborative Group) P. McGale, C. Taylor, and et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials Lancet 383 2014 2127 2135
17. P.T. Truong, M. Lesperance, A. Culhaci, H.A. Kader, C.H. Speers, and I.A. Olivotto Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy Int J Radiat Oncol Biol Phys 62 2005 175 182
18. P.T. Truong, B.T. Sadek, M.F. Lesperance, and et al. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy? Int J Radiat Oncol Biol Phys 88 2014 57 64
19. P.T. Truong, C.M. Yong, F. Abnousi, and et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy J Am Coll Surg 200 2005 912 921
20. R. Sharma, I. Bedrosian, A. Lucci, and et al. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy Ann Surg Oncol 17 2010 899 908
21. E. Yildirim, and U. Berberoglu Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified? Int J Radiat Oncol Biol Phys 68 2007 1024 1029
22. R. Jagsi, R.A. Raad, S. Goldberg, and et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation Int J Radiat Oncol Biol Phys 62 2005 1035 1039
23. J. Selz, D. Stevens, L. Jouanneau, A. Labib, and R. Le Scodan Prognostic value of molecular subtypes, Ki-67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy Int J Radiat Oncol Biol Phys 84 2012 1123 1132
24. A. Wallgren, M. Bonetti, R.D. Gelber, and et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII J Clin Oncol 21 2003 1205 1213
25. P. Karlsson, B.F. Cole, K.N. Price, and et al. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer J Clin Oncol 25 2007 2019 2026
26. J.M. Albert, A.M. Gonzalez-Angulo, M. Guray, and et al. Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer Int J Radiat Oncol Biol Phys 77 2010 1296 1302
27. E.P. Mamounas, G. Tang, B. Fisher, and et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 J Clin Oncol 28 2010 1677 1683
28. S.K. Childs, Y.H. Chen, M.M. Duggan, and et al. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy Int J Radiat Oncol Biol Phys 84 2012 1133 1138
29. G.M. Freedman, B.L. Fowble, A.L. Hanlon, and et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger Int J Radiat Oncol Biol Phys 41 1998 599 605
30. J. Wang, M. Shi, R. Ling, and et al. Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial Radiother Oncol 100 2011 200 204